These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37615111)

  • 1. Metabolomic Profiling of Cholesterol Efflux Capacity in a Multiethnic Population: Insights From MESA.
    Hunter WG; Smith AG; Pinto RC; Saldanha S; Gangwar A; Pahlavani M; Deodhar S; Wilkins J; Pandey A; Herrington D; Greenland P; Tzoulaki I; Rohatgi A
    Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):2030-2041. PubMed ID: 37615111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Determinants of Variation in Cholesterol Efflux: Observations from the Dallas Heart Study.
    Gangwar A; Deodhar SS; Saldanha S; Melander O; Abbasi F; Pearce RW; Collier TS; McPhaul MJ; Furtado JD; Sacks FM; Merrill NJ; McDermott JE; Melchior JT; Rohatgi A
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients.
    Gille A; D'Andrea D; Tortorici MA; Hartel G; Wright SD
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):953-963. PubMed ID: 29437574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses.
    van Capelleveen JC; Kastelein JJ; Zwinderman AH; van Deventer SJ; Collins HL; Adelman SJ; Round P; Ford J; Rader DJ; Hovingh GK
    J Clin Lipidol; 2016; 10(5):1137-1144.e3. PubMed ID: 27678430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density lipoprotein cholesterol efflux capacity is not associated with atherosclerosis and prevalence of cardiovascular outcome: The CODAM study.
    Josefs T; Wouters K; Tietge UJF; Annema W; Dullaart RPF; Vaisar T; Arts ICW; van der Kallen CJH; Stehouwer CDA; Schalkwijk CG; Goldberg IJ; Fisher EA; van Greevenbroek MMJ
    J Clin Lipidol; 2020; 14(1):122-132.e4. PubMed ID: 31791716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol efflux capacity and its association with prevalent metabolic syndrome in a multi-ethnic population (Dallas Heart Study).
    Akinmolayemi O; Saldanha S; Joshi PH; Deodhar S; Ayers CR; Neeland IJ; Rohatgi A
    PLoS One; 2021; 16(9):e0257574. PubMed ID: 34547056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDL cholesterol efflux capacity is related to disease activity in psoriatic arthritis patients.
    Ferraz-Amaro I; Hernández-Hernández MV; Armas-González E; Sánchez-Pérez H; Machado JD; Díaz-González F
    Clin Rheumatol; 2020 Jun; 39(6):1871-1880. PubMed ID: 31993889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL (High-Density Lipoprotein) Subclasses, Lipid Content, and Function Trajectories Across the Menopause Transition: SWAN-HDL Study.
    El Khoudary ( سمر رياض الخضري ) SR; Chen (陈曦润) X; Nasr ( ألكسس نصر ) AN; Billheimer J; Brooks MM; McConnell D; Orchard TJ; Crawford SL; Matthews KA; Rader DJ
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):951-961. PubMed ID: 33267661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased ABCA1 (ATP-Binding Cassette Transporter A1)-Specific Cholesterol Efflux Capacity in Schizophrenia.
    Luquain-Costaz C; Kockx M; Anastasius M; Chow V; Kontush A; Jessup W; Kritharides L
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2728-2737. PubMed ID: 32907370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of apolipoprotein B-depleted serum in cholesterol efflux capacity assays using immobilized liposome-bound gel beads.
    Horiuchi Y; Ohkawa R; Lai SJ; Shimano S; Hagihara M; Tohda S; Kameda T; Tozuka M
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30867253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis.
    Sánchez-Pérez H; Quevedo-Abeledo JC; de Armas-Rillo L; Rua-Figueroa Í; Tejera-Segura B; Armas-González E; Machado JD; García-Dopico JA; Jimenez-Sosa A; Rodríguez-Lozano C; Díaz-González F; González-Gay MA; Ferraz-Amaro I
    Rheumatology (Oxford); 2020 Oct; 59(10):2847-2856. PubMed ID: 32065639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight Loss and Exercise Alter the High-Density Lipoprotein Lipidome and Improve High-Density Lipoprotein Functionality in Metabolic Syndrome.
    Khan AA; Mundra PA; Straznicky NE; Nestel PJ; Wong G; Tan R; Huynh K; Ng TW; Mellett NA; Weir JM; Barlow CK; Alshehry ZH; Lambert GW; Kingwell BA; Meikle PJ
    Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):438-447. PubMed ID: 29284607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study.
    Ahmed MO; Byrne RE; Pazderska A; Segurado R; Guo W; Gunness A; Frizelle I; Sherlock M; Ahmed KS; McGowan A; Moore K; Boran G; McGillicuddy FC; Gibney J
    Diabetologia; 2021 Mar; 64(3):656-667. PubMed ID: 33169205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.
    He Y; Ronsein GE; Tang C; Jarvik GP; Davidson WS; Kothari V; Song HD; Segrest JP; Bornfeldt KE; Heinecke JW
    Circ Res; 2020 Oct; 127(9):1198-1210. PubMed ID: 32819213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From HDL-cholesterol to HDL-function: cholesterol efflux capacity determinants.
    Rhainds D; Tardif JC
    Curr Opin Lipidol; 2019 Apr; 30(2):101-107. PubMed ID: 30672808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Patterns of Extreme and Persistent Cholesterol Efflux Capacity.
    El-Ghazali A; Deodhar S; Saldanha S; Smyth B; Izbrand M; Gangwar A; Pahlavani M; Rohatgi A
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2588-2597. PubMed ID: 34433296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-Scale Analysis of Determinants, Stability, and Heritability of High-Density Lipoprotein Cholesterol Efflux Capacity.
    Koekemoer AL; Codd V; Masca NGD; Nelson CP; Musameh MD; Kaess BM; Hengstenberg C; Rader DJ; Samani NJ
    Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1956-1962. PubMed ID: 28860221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants at the APOE /C1/C2/C4 Locus Modulate Cholesterol Efflux Capacity Independently of High-Density Lipoprotein Cholesterol.
    Low-Kam C; Rhainds D; Lo KS; Barhdadi A; Boulé M; Alem S; Pedneault-Gagnon V; Rhéaume E; Dubé MP; Busseuil D; Hegele RA; Lettre G; Tardif JC
    J Am Heart Assoc; 2018 Aug; 7(16):e009545. PubMed ID: 30369316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol Efflux Capacity and Subclasses of HDL Particles in Healthy Women Transitioning Through Menopause.
    El Khoudary SR; Hutchins PM; Matthews KA; Brooks MM; Orchard TJ; Ronsein GE; Heinecke JW
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3419-28. PubMed ID: 27399353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis.
    Karpouzas GA; Papotti B; Ormseth SR; Palumbo M; Hernandez E; Adorni MP; Zimetti F; Budoff MJ; Ronda N
    J Transl Autoimmun; 2023 Dec; 7():100206. PubMed ID: 37484708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.